Explore News By Topic

01/15/2021

Statement From Jonathan Simons on American Cancer Society 2021 Facts and Figures

The American Cancer Society’s 2021 Facts & Figures holds good news for all Americans: overall, fewer people are dying from cancer, a 30-year trend due largely to advances in early detection and treatment for some cancers, including prostate cancer. It is equally encouraging that the death rate for prostate cancer... Read More

01/12/2021

PCF-Funded Research Inhibits Prostate Cancer Growth

New research, just published in Cancer Discovery, describes a new therapy with promising preclinical activity that is now being tested in clinical trials for very advanced prostate cancer patients. Early studies suggest this treatment has promising activity for the significant proportion of patients with advanced prostate cancer whose tumors remain... Read More

01/11/2021

Promising new treatment strategy for men with drug-resistant prostate cancer

A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not respond to existing treatments, or develops resistance to them, researchers report. Their study reveals the chemical structure of a new targeted drug known as CCS1477 and its method of action –... Read More

01/04/2021

Largest, most diverse ever study of prostate cancer genetics brings disparities into focus

"PCF has been funding research to understand and improve African American disparities in prostate cancer for more than 25 years. We believe that Dr. Chris Haiman’s research findings will lead to more effective prostate cancer precision screening strategies for men of West African ancestry. This is why PCF is partnering... Read More

12/31/2020

The Prostate Cancer Foundation Announces 2020 Challenge Awards Totaling More Than $11 Million For Prostate Cancer Research

LOS ANGELES, Calif., December 31, 2020 – The Prostate Cancer Foundation (PCF) today announced the 2020 Class of PCF Team Challenge Award recipients and a total of $11 million in funding for innovative prostate cancer research. PCF Challenge Awards fund international, multi-institutional, cross-disciplinary teams of investigators conducting highly innovative research... Read More

12/22/2020

The Prostate Cancer Foundation challenges Americans to kick the New Year Off Right by taking the “21 In 21” pledge

LOS ANGELES, Calif., December 22, 2020 – The Prostate Cancer Foundation (PCF) challenges Americans to show their support for men affected by prostate cancer and raise awareness about the link between healthy lifestyles and reduced cancer risk by making a New Year’s resolution to make 21 simple, healthy lifestyle changes in... Read More

12/21/2020

Breaking News: FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer

On Friday, December 18, 2020, the US FDA approved the first oral gonadotropin-releasing hormone (GnRH) receptor antagonist, relugolix, for adult patients with advanced prostate cancer. This is an important advance because it offers another option to patients who are taking hormone therapy. One of the mainstays of treatment for high-risk... Read More

12/16/2020

The Prostate Cancer Foundation Announces 2020 Young Investigator Awards Totaling $6 Million for Prostate Cancer Research

LOS ANGELES, Calif., December 16, 2020 – The Prostate Cancer Foundation (PCF) today announced the Class of 2020 Young Investigator Award recipients totaling $6 million in funding for innovative prostate cancer research. PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the... Read More

12/16/2020

The Prostate Cancer Foundation and Cancer Research Innovation In Science Announce 2020 Young Investigator Award Winners

LOS ANGELES, Calif., December 16, 2020 – The Prostate Cancer Foundation (PCF) and Cancer Research Innovation in Science (CRIS) today announced two new CRIS Cancer Foundation-PCF Young Investigator Awards. The awards, each in the amount of $250,000, are granted to future research leaders at two of the United Kingdom’s leading... Read More

12/01/2020

UCLA, UCSF gain FDA approval for prostate cancer imaging technique

The University of California's two nationally ranked medical centers, UCSF and UCLA, and their nuclear medicine teams have obtained approval from the U.S. Food and Drug Administration to offer a new imaging technique for prostate cancer that locates cancer lesions in the pelvic area and other parts of the body... Read More